Učitavanje...
Alterations of mast cells and TGF-β1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis
AIM: Silymarin is a potent antioxidant, antiinflammatory and anti-fibrogenic agent in the liver, which is mediated by alteration of hepatic Kupffer cell function, lipid peroxidation, and collagen production. Especially, in hepatic fibrogenesis, mast cells are expressed in chronic inflammatory condit...
Spremljeno u:
Izdano u: | World J Gastroenterol |
---|---|
Glavni autori: | , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Baishideng Publishing Group Inc
2005
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4250703/ https://ncbi.nlm.nih.gov/pubmed/15754394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i8.1141 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|